Subscribe To
Children's medicine face supply shortages as demand spikes
Erin Fox, senior pharmacy director at University of Utah Health, joins 'The Exchange' to discuss the current shortage in children's pain medicine, the...
December 23, 2022, 3:01 pm
Intercept resubmits new drug application to u.s. fda for obeticholic acid in patients with liver fibrosis due to nash
NDA supported by robust NASH clinical development program, including two positive interim analyses from the Phase 3 REGENERATE study NDA includes deta...
December 23, 2022, 12:50 pm
Outlook therapeutics announces $25 million registered direct offering priced at-the-market under nasdaq rules
ISELIN, N.J., Dec. 23, 2022 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutica...
December 23, 2022, 11:00 am
Voyageur pharmaceuticals closes first tranche of c$650,000 private placement
Voyageur pharmaceuticals Ltd (TSX-V:VM, OTC:VYYRF) announced the completion of the first tranche of a p...
December 23, 2022, 10:39 am
You can boost your passive income with these 3 dividend raises
A trio of top companies in the agricultural machinery, waste removal, and pharmaceutical industries rec...
December 23, 2022, 9:02 am
Madrigal pharmaceuticals: upcoming windfall profits
Like an early Christmas/Hanukkah present, Madrigal shares rallied over 268% in one session due to the positive MAESTRO-NASH data. The shares continue ...
December 23, 2022, 8:31 am
Why madrigal pharmaceuticals was a top stock this week
Biotech bulls stampeded the company following its latest clinical update....
December 23, 2022, 7:03 am
Seagen: 2023 shaping up to be a breakout year
SGEN has been under pressure since a rumored takeover deal by pharmaceutical giant Merck & Co. fell thr...
December 22, 2022, 5:31 pm
Bioxcel therapeutics to present at 41st annual j.p. morgan healthcare conference
NEW HAVEN, Conn., Dec. 22, 2022 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceu...
December 22, 2022, 12:00 pm
Merck, sichuan kelun enter cancer collaboration, with milestone payments up to $9.3 billion
Merck & Co. Inc. MRK, -0.34% said Thursday that it entered into an agreement with Sichuan Kelun pharmaceutical...
December 22, 2022, 9:41 am
Oric's stock rallies on multiple myeloma deal with pfizer
Shares of Oric pharmaceuticals Inc. ORIC, +2.04% soared about 56% in premarket trading on Thursday, the...
December 22, 2022, 8:38 am
Oric pharmaceuticals (oric) stock rockets 58% on pfizer deal
ORIC pharmaceuticals (NASDAQ: ORIC ) stock is rocketing higher after the company revealed a collaborati...
December 22, 2022, 8:25 am
Harmony biosciences to present at the 41st annual j.p. morgan healthcare conference
PLYMOUTH MEETING, Pa. , Dec. 22, 2022 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (Nasdaq: HRMY), a ...
December 22, 2022, 8:05 am
Okyo pharma receives us fda license to start phase 2 study
OKYO Pharma Ltd (LSE:OKYO, NASDAQ:OKYO) said its dry eye disease treatment has received its investigational new drug (IND) application from the US Fo...
December 22, 2022, 2:57 am
Angion receives nasdaq notice regarding minimum bid price requirements
UNIONDALE, N.Y., Dec. 21, 2022 (GLOBE NEWSWIRE) — Angion Biomedica Corp (NASDAQ:ANGN), a biopharmaceutical...
December 22, 2022, 2:50 am
Immupharma says it has ‘clear objective' to advance lupus treatment to next clinical trial in 2023
ImmuPharma PLC (AIM:IMM, OTC:IMMPF) has expressed optimism about 2023, during which it aims to progress its lupus treatment Lupuzor to its next clinic...
December 22, 2022, 2:46 am
Oric pharmaceuticals announces clinical development collaboration with pfizer for oric-533 in multiple myeloma and concurrent $25 million equity investment by pfizer
ORIC and Pfizer have entered into a clinical development collaboration for a Phase 2 study of ORIC-533 in combination with elranatamab in multiple mye...
December 21, 2022, 10:48 pm
Eagle pharmaceuticals to present at the 41st annual j.p. morgan healthcare conference
WOODCLIFF LAKE, N.J., Dec. 21, 2022 (GLOBE NEWSWIRE) -- Eagle pharmaceuticals, Inc. (Nasdaq: EGRX) (“...
December 21, 2022, 4:30 pm
Arrowhead pharmaceuticals to present at 41st annual j.p. morgan healthcare conference
PASADENA, Calif.--( BUSINESS WIRE )--Arrowhead pharmaceuticals Inc. (NASDAQ: ARWR) today announced that...
December 21, 2022, 4:00 pm
Growth, innovation could fuel pharma etf rebound
For much of 2020 and 2021, the pharmaceutical stock investment thesis revolved around development and d...
December 21, 2022, 12:31 pm